Wright Medical's improved hip liner:
This article was originally published in Clinica
Executive Summary
The US FDA has given Wright Medical Group 510(k) clearance to market its wear-reducing polyethylene liner for use with its Lineage acetabular hip system. The A-CLASS liner is produced with a proprietary crosslinking process that makes it significantly more wear-resistant than traditional Lineage polyethylene liners, thereby reducing the potential for dissolution of adjacent bone due to osteolysis, said the Arlington, Tennessee firm. Tests have shown that the product reduces wear debris by up to 94%, when compared with current Lineage polyethylene liners.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.